REPRICAZ Trademark

Trademark Overview

On Saturday, March 24, 2018, a trademark application was filed for REPRICAZ with the United States Patent and Trademark Office. The USPTO has given the REPRICAZ trademark a serial number of 79235518. The federal status of this trademark filing is REGISTERED as of Tuesday, May 18, 2021. This trademark is owned by NOVARTIS AG. The REPRICAZ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, anti-infectives, anti-inflammatories, antibacterial pharmaceuticals, antibiotics, antifungal preparations, antivirals; cardiovascular pharmaceuticals, dermatological pharmaceutical products, inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; phar...
repricaz

General Information

Serial Number79235518
Word MarkREPRICAZ
Filing DateSaturday, March 24, 2018
Status700 - REGISTERED
Status DateTuesday, May 18, 2021
Registration Number6350484
Registration DateTuesday, May 18, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 2, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, anti-infectives, anti-inflammatories, antibacterial pharmaceuticals, antibiotics, antifungal preparations, antivirals; cardiovascular pharmaceuticals, dermatological pharmaceutical products, inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 3, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH
Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH
Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events

Event DateEvent Description
Sunday, October 24, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, August 27, 2021FINAL DISPOSITION NOTICE SENT TO IB
Friday, August 27, 2021FINAL DISPOSITION PROCESSED
Wednesday, August 18, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 18, 2021REGISTERED-PRINCIPAL REGISTER
Sunday, March 7, 2021NOTIFICATION PROCESSED BY IB
Tuesday, March 2, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 2, 2021PUBLISHED FOR OPPOSITION
Wednesday, February 10, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 10, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 10, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 25, 2021ELECTRONIC RECORD REVIEW COMPLETE
Friday, July 31, 2020ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Thursday, July 30, 2020ATTORNEY REVIEW COMPLETED
Friday, July 17, 2020CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Wednesday, May 27, 2020REG. CANCELLED - RESTORED TO PENDENCY
Wednesday, May 27, 2020ASSIGNED TO PETITION STAFF
Tuesday, May 26, 2020REQUEST TO CANCEL INADVERTENTLY ISSUED REGISTRATION RECEIVED
Friday, May 31, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, May 15, 2019FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, May 14, 2019FINAL DISPOSITION PROCESSED
Monday, April 22, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 22, 2019REGISTERED-PRINCIPAL REGISTER
Thursday, December 20, 2018CORRECTION TRANSACTION RECEIVED FROM IB
Friday, November 23, 2018NOTIFICATION PROCESSED BY IB
Tuesday, November 6, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 6, 2018PUBLISHED FOR OPPOSITION
Wednesday, October 17, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 17, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 17, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 4, 2018LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, September 28, 2018ASSIGNED TO LIE
Tuesday, September 18, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 17, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 17, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 17, 2018TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, September 13, 2018NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, September 13, 2018FINAL REFUSAL E-MAILED
Thursday, September 13, 2018FINAL REFUSAL WRITTEN
Thursday, August 23, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 23, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 23, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 21, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 21, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 10, 2018REFUSAL PROCESSED BY IB
Monday, July 16, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, July 16, 2018REFUSAL PROCESSED BY MPU
Saturday, July 7, 2018APPLICATION FILING RECEIPT MAILED
Wednesday, July 4, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, July 3, 2018NON-FINAL ACTION WRITTEN
Tuesday, July 3, 2018ASSIGNED TO EXAMINER
Tuesday, July 3, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, June 29, 2018LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, June 28, 2018SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

repricaz preparations pharmaceutical system prevention treatment diseases disorders anti pharmaceuticals endocrine